Aldeyra Therapeutics announced positive top-line data from a Phase 2 clinical trial comparing reproxalap ophthalmic solution 0.25% (reproxalap) versus Novartis’ Xiidra (lifitegrast ophthalmic solution 5%),…
An eye condition known as inherited retinal degeneration can make even the most mundane tasks—like cooking, driving, and walking down the sidewalk—difficult or impossible, and…
Ribomic announced topline data from the Phase 2 TOFU study of RBM-007 in patients with Wet Age-Related Macular Degeneration (wAMD). The double-masked, randomized, active-controlled trial…
Novaliq announced positive results from the second pivotal Phase 3 trial (ESSENCE-2) evaluating CyclASol for the treatment of dry eye disease (DED). CyclASol is a topical, anti-inflammatory…
Wayne State University School of Medicine researchers came up with what appears to be a breakthrough in understanding how to heal a cornea infected with…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
